• Abdullah, F., Myers, J., Basu, D., Tintinger, G., Ueckermann, V., Mathebula, M., Ramlall, R., Spoor, S., de Villiers, T., Van der Walt, Z., Cloete, J., Soma-Pillay, P., Rheeder, P., Paruk, F., Engelbrecht, A., Lalloo, V., Myburg, M., Kistan, J., van Hougenhouck-Tulleken, W., Boswell, M.T., Gray, G., Welch, R., Blumberg, L., Jassat, W., 2022. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in Tshwane, South Africa. Int. J. Infect. Dis. 116, 38-42.

  • Accorsi, E.K., Britton, A., Fleming-Dutra, K.E., Smith, Z.R., Shang, N., Derado, G., Miller, J., Schrag, S.J., Verani, J.R., 2022. Association between 3 doses of mRNA COVID-19 vaccine and symptomatic infection caused by the Sars-CoV-2 omicron and delta variants. JAMA 327, 639-651.

  • Brandal, L.T., MacDonald, E., Veneti, L., Ravlo, T., Lange, H., Naseer, U., Feruglio, S., Bragstad, K., Hungnes, O., Ødeskaug, L.E., Hagen, F., Hanch-Hansen, K.E., Lind, A., Watle, S.V., Taxt, A.M., Johansen, M., Vold, L., Aavitsland, P., Nygård, K., Madslien, E.H., 2021. Outbreak caused by the sars-cov-2 omicron variant in Norway, november to december 2021. Euro Surveill. 26, 2101147.

  • Chen, J., Wang, R., Gilby, N.B., Wei, G.W., 2022. Omicron variant (b.1.1.529):infectivity, vaccine breakthrough, and antibody resistance. J. Chem. Inf. Model. 62, 412-422.

  • GISAID Initiative, 2022. Tracking of variants. Accessed July 16, 2022. https://www.gisaid.org/hcov19-variants/.

  • Greaney, A.J., Starr, T.N., Gilchuk, P., Zost, S.J., Binshtein, E., Loes, A.N., Hilton, S.K., Huddleston, J., Eguia, R., Crawford, K., Dingens, A.S., Nargi, R.S., Sutton, R.E., Suryadevara, N., Rothlauf, P.W., Liu, Z., Whelan, S., Carnahan, R.H., Crowe Jr., J.E., Bloom, J.D., 2021. Complete mapping of mutations to the Sars-CoV-2 spike receptorbinding domain that escape antibody recognition. Cell Host Microbe 29, 44-57 e49.

  • Harvey, W.T., Carabelli, A.M., Jackson, B., Gupta, R.K., Thomson, E.C., Harrison, E.M., Ludden, C., Reeve, R., Rambaut, A.,, COVID-19 Genomics UK (COG-UK) Consortium, Peacock, S.J., Robertson, D.L., 2021. Sars-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409-424.

  • He, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., Dwyer, D.E., 2005. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int. J. Infect. Dis. 9, 323-330.

  • Iacobucci, G., 2021. Covid-19:runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. BMJ 375, n3103.

  • Kim, M.K., Lee, B., Choi, Y.Y., Um, J., Lee, K.S., Sung, H.K., Kim, Y., Park, J.S., Lee, M., Jang, H.C., Bang, J.H., Chung, K.H., Jeon, J., 2022. Clinical characteristics of 40 patients infected with the sars-cov-2 omicron variant in korea. J. Kor. Med. Sci. 37, e31.

  • Lee, S.W., Ha, E.K., Yeniova, A.Ö., Moon, S.Y., Kim, S.Y., Koh, H.Y., Yang, J.M., Jeong, S.J., Moon, S.J., Cho, J.Y., Yoo, I.K., Yon, D.K., 2021. Severe clinical outcomes of covid-19 associated with proton pump inhibitors:a nationwide cohort study with propensity score matching. Gut 70, 76-84.

  • Levi, R., Azzolini, E., Pozzi, C., Ubaldi, L., Lagioia, M., Mantovani, A., Rescigno, M., 2021. One dose of sars-cov-2 vaccine exponentially increases antibodies in individuals who have recovered from symptomatic covid-19. J. Clin. Invest. 131, e149154.

  • Li, K., Wu, J., Wu, F., Guo, D., Chen, L., Fang, Z., Li, C., 2020. The clinical and chest ct features associated with severe and critical covid-19 pneumonia. Invest. Radiol. 55, 327-331.

  • Liu, Y., Mao, B., Liang, S., Yang, J.W., Lu, H.W., Chai, Y.H., Wang, L., Zhang, L., Li, Q.H., Zhao, L., He, Y., Gu, X.L., Ji, X.B., Li, L., Jie, Z.J., Li, Q., Li, X.Y., Lu, H.Z., Zhang, W.H., Song, Y.L., Qu, J.M., Xu, J.F., Shanghai Clinical Treatment Experts Group for COVID-19, 2020. Association between age and clinical characteristics and outcomes of covid-19. Eur. Respir. J. 55, 2001112.

  • Löhr, P., Schiele, S., Arndt, T.T., Grützner, S., Claus, R., Römmele, C., Müller, G., Schmid, C., Dennehy, K.M., Rank, A., 2021. Impact of age and gender on lymphocyte subset counts in patients with covid-19. Cytometry. https://doi.org/10.1002/cyto.a.24470.

  • Luo, H., Liu, S., Wang, Y., Phillips-Howard, P.A., Ju, S., Yang, Y., Wang, D., 2020. Age differences in clinical features and outcomes in patients with COVID-19, Jiangsu, China:a retrospective, multicentre cohort study. BMJ Open 10, e039887.

  • Menni, C., Valdes, A.M., Polidori, L., Antonelli, M., Penamakuri, S., Nogal, A., Louca, P., May, A., Figueiredo, J.C., Hu, C., Molteni, E., Canas, L., Österdahl, M.F., Modat, M., Sudre, C.H., Fox, B., Hammers, A., Wolf, J., Capdevila, J., Chan, A.T., David, S.P., Steves, C.J., Ourselin, S., Spector, T.D., 2022. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance:a prospective observational study from the ZOE COVID study. Lancet 399, 1618-1624.

  • Thomas, L., Li, F., Pencina, M., 2020. Using propensity score methods to create target populations in observational clinical research. JAMA 323, 466-467.

  • Ulloa, A.C., Buchan, S.A., Daneman, N., Brown, K.A., 2022. Estimates of SARS-CoV-2 omicron variant severity in Ontario, Canada. JAMA 327, 1286-1288.

  • Walls, A.C., Park, Y.J., Tortorici, M.A., Wall, A., McGuire, A.T., Veesler, D., 2020. Structure, function, and antigenicity of the sars-cov-2 spike glycoprotein. Cell 181, 281-292 e286.

  • World Health Organization, 2022a. WHO Coronavirus disease (COVID-19) pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. (Accessed 16 July 2022).

  • World Health Organization, 2022b. Tracking SARS-CoV-2 variants. https://www.wh o.int/en/activities/tracking-SARS-CoV-2-variants/. (Accessed 18 July 2022).

  • Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., Zhou, Q., 2020. Structural basis for the recognition of sars-cov-2 by full-length human ACE2. Science 367, 1444-1448.

  • Zhang, J.J., Dong, X., Cao, Y.Y., Yuan, Y.D., Yang, Y.B., Yan, Y.Q., Akdis, C.A., Gao, Y.D., 2020. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 75, 1730-1741.